Hydrochlorothiazide; Irbesartan was first introduced by Sanofi Aventis Us Llc in its drug Avalide on Sep 30, 1997. 16 different companies have introduced drugs containing Hydrochlorothiazide; Irbesartan.
Hydrochlorothiazide; Irbesartan Patents
Given below is the list of patents protecting Hydrochlorothiazide; Irbesartan, along
with the drug name that holds that patent and the company name owning that
drug.
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List
Hydrochlorothiazide; Irbesartan Generic API Manufacturers
Several generic applications have been filed for Hydrochlorothiazide; Irbesartan. The first generic version for Hydrochlorothiazide; Irbesartan was by Teva Pharmaceuticals Usa Inc and was approved on Mar 30, 2012. And the latest generic version is by Unichem Laboratories Ltd and was approved on Sep 19, 2017.
Given below is the list of companies who have filed for
Hydrochlorothiazide; Irbesartan generic, along with the locations of their manufacturing plants worldwide.
1. ALEMBIC
Alembic Pharmaceuticals Ltd has filed for 3 different strengths of generic version for Hydrochlorothiazide; Irbesartan. All of these versions come by the name IRBESARTAN AND HYDROCHLOROTHIAZIDE. Given below are the
details of the strengths of this generic introduced by
Alembic.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
12.5MG; 150MG
tablet
Prescription
ORAL
AB
Oct 15, 2012
12.5MG; 300MG
tablet
Prescription
ORAL
AB
Oct 15, 2012
25MG; 300MG
tablet
Prescription
ORAL
AB
Oct 12, 2016
Manufacturing Plant Locations
New
Alembic's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Alembic as present at those locations.
Apotex Inc has filed for 2 different strengths of generic version for Hydrochlorothiazide; Irbesartan. All of these versions come by the name IRBESARTAN AND HYDROCHLOROTHIAZIDE. Given below are the
details of the strengths of this generic introduced by
Apotex Inc.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
12.5MG; 150MG
tablet
Discontinued
ORAL
N/A
Oct 15, 2012
12.5MG; 300MG
tablet
Discontinued
ORAL
N/A
Oct 15, 2012
Manufacturing Plant Locations
New
Apotex Inc's manufacturing plants are situated in 1 country - Canada. Given below are the details of these plant locations as well as the firm names of Apotex Inc as present at those locations.
Country
City
Firm Name
Canada
Toronto
Apotex Inc.
North York
Apotex Inc.
Richmond Hill
Apotex Inc.
3. ATLAS PHARMS LLC
Atlas Pharmaceuticals Llc has filed for 3 different strengths of generic version for Hydrochlorothiazide; Irbesartan. All of these versions come by the name IRBESARTAN AND HYDROCHLOROTHIAZIDE. Given below are the
details of the strengths of this generic introduced by
Atlas Pharms Llc.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
25MG; 300MG
tablet
Discontinued
ORAL
N/A
Jan 15, 2016
12.5MG; 300MG
tablet
Discontinued
ORAL
N/A
Jan 15, 2016
12.5MG; 150MG
tablet
Discontinued
ORAL
N/A
Jan 15, 2016
4. AUROBINDO PHARMA LTD
Aurobindo Pharma Ltd has filed for 3 different strengths of generic version for Hydrochlorothiazide; Irbesartan. All of these versions come by the name IRBESARTAN AND HYDROCHLOROTHIAZIDE. Given below are the
details of the strengths of this generic introduced by
Aurobindo Pharma Ltd.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
12.5MG; 150MG
tablet
Prescription
ORAL
AB
Feb 22, 2013
12.5MG; 300MG
tablet
Prescription
ORAL
AB
Feb 22, 2013
25MG; 300MG
tablet
Prescription
ORAL
AB
Mar 31, 2016
Manufacturing Plant Locations
New
Aurobindo Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma Ltd as present at those locations.
Country
City
Firm Name
India
Medchal
Aurobindo Pharma Ltd
5. DR REDDYS LABS LTD
Dr Reddys Laboratories Ltd has filed for 2 different strengths of generic version for Hydrochlorothiazide; Irbesartan. All of these versions come by the name IRBESARTAN AND HYDROCHLOROTHIAZIDE. Given below are the
details of the strengths of this generic introduced by
Dr Reddys Labs Ltd.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
12.5MG; 300MG
tablet
Prescription
ORAL
AB
Sep 27, 2012
12.5MG; 150MG
tablet
Prescription
ORAL
AB
Sep 27, 2012
6. HIKMA
Hikma Pharmaceuticals Usa Inc has filed for 3 different strengths of generic version for Hydrochlorothiazide; Irbesartan. All of these versions come by the name IRBESARTAN AND HYDROCHLOROTHIAZIDE. Given below are the
details of the strengths of this generic introduced by
Hikma.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
12.5MG; 150MG
tablet
Prescription
ORAL
AB
Oct 15, 2012
12.5MG; 300MG
tablet
Prescription
ORAL
AB
Oct 15, 2012
25MG; 300MG
tablet
Prescription
ORAL
AB
Jun 8, 2017
Manufacturing Plant Locations
New
Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.
Country
City
Firm Name
United States
Dayton
Hikma Injectables USA Inc
Cherry Hill
Hikma Pharmaceuticals USA Inc.
Eatontown
Hikma Pharmaceuticals USA, Inc.
Carlsbad
Hikma Cali Inc. DBA Leucadia Pharmaceuticals
Portugal
Terrugem Snt
Hikma Farmaceutica, (Portugal) S.A.
Jordan
Amman
Hikma Pharmaceuticals LLC
7. HISUN PHARM HANGZHOU
Hisun Pharmaceutical (hangzhou) Co Ltd has filed for 2 different strengths of generic version for Hydrochlorothiazide; Irbesartan. All of these versions come by the name IRBESARTAN AND HYDROCHLOROTHIAZIDE. Given below are the
details of the strengths of this generic introduced by
Hisun Pharm Hangzhou.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
12.5MG; 300MG
tablet
Prescription
ORAL
AB
Oct 14, 2016
12.5MG; 150MG
tablet
Prescription
ORAL
AB
Oct 14, 2016
8. LUPIN LTD
Lupin Ltd has filed for 2 different strengths of generic version for Hydrochlorothiazide; Irbesartan. All of these versions come by the name IRBESARTAN AND HYDROCHLOROTHIAZIDE. Given below are the
details of the strengths of this generic introduced by
Lupin Ltd.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
12.5MG; 150MG
tablet
Prescription
ORAL
AB
Feb 27, 2013
12.5MG; 300MG
tablet
Prescription
ORAL
AB
Feb 27, 2013
Manufacturing Plant Locations
New
Lupin Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Lupin Ltd as present at those locations.
Country
City
Firm Name
India
Aurangabad
Lupin Ltd.
9. MACLEODS PHARMS LTD
Macleods Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Hydrochlorothiazide; Irbesartan. All of these versions come by the name IRBESARTAN AND HYDROCHLOROTHIAZIDE. Given below are the
details of the strengths of this generic introduced by
Macleods Pharms Ltd.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
12.5MG; 300MG
tablet
Prescription
ORAL
AB
Sep 27, 2012
12.5MG; 150MG
tablet
Prescription
ORAL
AB
Sep 27, 2012
10. NORVIUM BIOSCIENCE
Norvium Bioscience Llc has filed for 3 different strengths of generic version for Hydrochlorothiazide; Irbesartan. All of these versions come by the name IRBESARTAN AND HYDROCHLOROTHIAZIDE. Given below are the
details of the strengths of this generic introduced by
Norvium Bioscience.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
12.5MG; 150MG
tablet
Discontinued
ORAL
N/A
Sep 27, 2012
12.5MG; 300MG
tablet
Discontinued
ORAL
N/A
Sep 27, 2012
25MG; 300MG
tablet
Discontinued
ORAL
N/A
Jul 20, 2016
11. PRINSTON INC
Prinston Pharmaceutical Inc has filed for 2 different strengths of generic version for Hydrochlorothiazide; Irbesartan. All of these versions come by the name IRBESARTAN AND HYDROCHLOROTHIAZIDE. Given below are the
details of the strengths of this generic introduced by
Prinston Inc.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
12.5MG; 300MG
tablet
Prescription
ORAL
AB
May 9, 2014
12.5MG; 150MG
tablet
Prescription
ORAL
AB
May 9, 2014
12. SANDOZ
Sandoz Inc has filed for 2 different strengths of generic version for Hydrochlorothiazide; Irbesartan. All of these versions come by the name IRBESARTAN AND HYDROCHLOROTHIAZIDE. Given below are the
details of the strengths of this generic introduced by
Sandoz.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
12.5MG; 150MG
tablet
Prescription
ORAL
AB
Sep 27, 2012
12.5MG; 300MG
tablet
Prescription
ORAL
AB
Sep 27, 2012
Manufacturing Plant Locations
New
Sandoz's manufacturing plants are situated in 4 countries - Austria, United States, Spain, India. Given below are the details of these plant locations as well as the firm names of Sandoz as present at those locations.
Country
City
Firm Name
Austria
Langkampfen
Sandoz GmbH
Kundl
Sandoz GmbH
United States
Princeton
Sandoz Inc
East Hanover
Sandoz Incorporated
Spain
Les Franqueses Del Valles
Sandoz Industrial Products S.A.
Palafolls
Sandoz Industrial Products, S.A.
India
Navi Mumbai
Sandoz Private Limited
13. TEVA
Teva Pharmaceuticals Usa Inc has filed for 3 different strengths of generic version for Hydrochlorothiazide; Irbesartan. All of these versions come by the name IRBESARTAN AND HYDROCHLOROTHIAZIDE. Given below are the
details of the strengths of this generic introduced by
Teva.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
12.5MG; 150MG
tablet
Prescription
ORAL
AB
Mar 30, 2012
12.5MG; 300MG
tablet
Prescription
ORAL
AB
Mar 30, 2012
25MG; 300MG
tablet
Discontinued
ORAL
N/A
Mar 30, 2012
Manufacturing Plant Locations
New
Teva's manufacturing plants are situated in 6 countries - United States, India, Canada, Czech Republic, Ireland, Israel. Given below are the details of these plant locations as well as the firm names of Teva as present at those locations.
Country
City
Firm Name
United States
Horsham
Teva Branded Pharmaceutical Products R&D
Malvern
Teva Branded Pharmaceutical Products R&D, Inc.
Fort Dodge
TEVA Animal Health Inc
Miami
Teva Branded Pharmaceutical Products R & D, Inc.
India
Gajraula, Amroha
Teva API India Private Ltd.
Bhind
Teva API India Ltd- Malanpur
Canada
Markham
Teva Canada Limited
Scarborough
Teva Canada Limited
Stouffville
Teva Canada Limited
Czech Republic
Opava
Teva Czech Industries s.r.o.
Ireland
Dundalk
Teva Laboratories Ireland Ltd
Israel
Kiryat-Shmona
TEVA Medical Ltd.
14. UNICHEM
Unichem Laboratories Ltd has filed for 2 different strengths of generic version for Hydrochlorothiazide; Irbesartan. All of these versions come by the name IRBESARTAN AND HYDROCHLOROTHIAZIDE. Given below are the
details of the strengths of this generic introduced by
Unichem.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
12.5MG; 300MG
tablet
Discontinued
ORAL
N/A
Sep 19, 2017
12.5MG; 150MG
tablet
Discontinued
ORAL
N/A
Sep 19, 2017
Manufacturing Plant Locations
New
Unichem's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Unichem as present at those locations.
Country
City
Firm Name
India
Ghaziabad
Unichem Laboratories Ltd.
Mumbai
Unichem Laboratories Limited
Kolhapur
Unichem Laboratories Limited
Pilerne Bardez
Unichem Laboratories Limited
Pithampur
Unichem Laboratories Limited
District Raigad
Unichem Laboratories Ltd
United States
Hasbrouck Heights
Unichem Pharmaceuticals Usa Inc
East Brunswick
Unichem Pharmaceuticals USA Inc.
15. WATSON LABS INC
Watson Laboratories Inc has filed for 2 different strengths of generic version for Hydrochlorothiazide; Irbesartan. All of these versions come by the name IRBESARTAN AND HYDROCHLOROTHIAZIDE. Given below are the
details of the strengths of this generic introduced by
Watson Labs Inc.
